Community Pharmacy England (CPE) - News updates


Pharmacy First Update: A message from our CEO

Community Pharmacy England CEO Janet Morrison has given a video update on Pharmacy First, addressing some of the concerns that pharmacy owners have, particularly around the thresholds for monthly payments. In her video message, Janet notes the incredible early achievements of Pharmacy First as well as outlining the importance of the service and how it [...] The post Pharmacy First Update: A message from our CEO appeared first on Community Pharmacy England.

MHRA Class 3 Medicines Recall: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules (Accord Healthcare Ltd)

Class 3 Medicines Recall: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules (Accord Healthcare Ltd) Drug alert number: EL (24)A/25 Date issued: 02 July 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules (Accord Healthcare Ltd) [...] The post MHRA Class 3 Medicines Recall: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules (Accord Healthcare Ltd) appeared first on Community Pharmacy England.

DHSC’s June 2024 Price Concessions – Final Update

The Department of Health and Social Care (DHSC) has today (02/07/2024) confirmed the following list of final price concessions for June 2024. This announcement comes in the following month and follows the decision by DHSC to impose changes to concessions pricing from April 2024 to try to manage purchase margins. DHSC has applied its new margin reduction formula as [...] The post DHSC’s June 2024 Price Concessions – Final Update appeared first on Community Pharmacy England.

July 2024 Category M prices announced

The Drug Tariff Category M pricelist for July 2024 has been published on the NHS Business Services Authority (NHSBSA) website. The new July Category M prices include no adjustment for margin, however the new prices will still reflect movements in the underlying market (i.e. movements in buying prices of medicines). These are systematic and not subject [...] The post July 2024 Category M prices announced appeared first on Community Pharmacy England.

Market Exit for moving to Primary Care Support England (PCSE)

Last week NHS England announced that PCSE would take over the administration and processing of notices of withdrawal from a pharmaceutical list. From today, 1st July 2024, any notices of withdrawal should be sent to pcse.marketentry@nhs.net. Any notices submitted prior to 1st July 2024 will still be processed by the ICB directly and any queries [...] The post Market Exit for moving to Primary Care Support England (PCSE) appeared first on Community Pharmacy England.

2024/25 Community Pharmacy Assurance Framework (CPAF) screening questionnaire has opened

The 2024/25 Community Pharmacy Assurance Framework (CPAF) screening questionnaire is now available for completion until midnight on Wednesday 31st July 2024. As a result of NHS regulations introduced at the end of 2020, completion of CPAF is now a requirement of the Terms of Service. Therefore, pharmacy owners must complete the screening questionnaire and, if required, [...] The post 2024/25 Community Pharmacy Assurance Framework (CPAF) screening questionnaire has opened appeared first on Community Pharmacy England.

Yorkshire & the Humber and West Midlands Pharmacy Owners: Book your place for our regional roadshows

Whatever the outcome of the 2024 General Election, the next Government and its approach to community pharmacy will be critical for the future of the sector. Pharmacy owners across Yorkshire & the Humber and the West Midlands are invited to hear more about what lies ahead for community pharmacy, and how Community Pharmacy England will [...] The post Yorkshire & the Humber and West Midlands Pharmacy Owners: Book your place for our regional roadshows appeared first on Community Pharmacy England.

Medicine Supply Notification: Disopyramide (Rythmodan Retard® ) 250mg modified-release tablets and disopyramide (Rythmodan® ) 100mg capsules. Updated

1st July 2024: Updates to the further information hosted on the Medicines Supply Tool,  have been published.  Department of Health and Social Care (DHSC) has issued a medicine supply notification for Disopyramide (Rythmodan Retard®) 250mg modified-release tablets and disopyramide (Rythmodan®) 100mg capsules. MSN/2024/075 Tier 2 – medium impact Date of issue: 5th June 2024 Disopyramide [...] The post Medicine Supply Notification: Disopyramide (Rythmodan Retard® ) 250mg modified-release tablets and disopyramide (Rythmodan® ) 100mg capsules. Updated appeared first on Community Pharmacy England.

GP Connect: Update Record rolls out to most pharmacies

EMIS Pinnacle started rolling out the GP Connect Update Record feature to all community pharmacy teams using PharmOutcomes from Friday 28th June 2024. Initially, this covers Hypertension Case-finding Service and Pharmacy Contraception Service consultations. Update Record is a new feature that CPCF IT system suppliers have been adding to their systems, with Cegedim and Positive [...] The post GP Connect: Update Record rolls out to most pharmacies appeared first on Community Pharmacy England.

DHSC’s June 2024 Price Concessions – 2nd Update

The Department of Health and Social Care (DHSC) has today (28/06/2024) confirmed the following list of price concessions for June 2024. This announcement comes late in the month and follows the decision to impose changes to concessions pricing from April 2024 to try to manage purchase margins. DHSC has applied its new margin reduction formula as a final [...] The post DHSC’s June 2024 Price Concessions – 2nd Update appeared first on Community Pharmacy England.